Influenza Genome Sequencing Project

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
Flu

WikiDoc Resources for

Influenza Genome Sequencing Project

Articles

Most recent articles on Influenza Genome Sequencing Project

Most cited articles on Influenza Genome Sequencing Project

Review articles on Influenza Genome Sequencing Project

Articles on Influenza Genome Sequencing Project in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Influenza Genome Sequencing Project

Images of Influenza Genome Sequencing Project

Photos of Influenza Genome Sequencing Project

Podcasts & MP3s on Influenza Genome Sequencing Project

Videos on Influenza Genome Sequencing Project

Evidence Based Medicine

Cochrane Collaboration on Influenza Genome Sequencing Project

Bandolier on Influenza Genome Sequencing Project

TRIP on Influenza Genome Sequencing Project

Clinical Trials

Ongoing Trials on Influenza Genome Sequencing Project at Clinical Trials.gov

Trial results on Influenza Genome Sequencing Project

Clinical Trials on Influenza Genome Sequencing Project at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Influenza Genome Sequencing Project

NICE Guidance on Influenza Genome Sequencing Project

NHS PRODIGY Guidance

FDA on Influenza Genome Sequencing Project

CDC on Influenza Genome Sequencing Project

Books

Books on Influenza Genome Sequencing Project

News

Influenza Genome Sequencing Project in the news

Be alerted to news on Influenza Genome Sequencing Project

News trends on Influenza Genome Sequencing Project

Commentary

Blogs on Influenza Genome Sequencing Project

Definitions

Definitions of Influenza Genome Sequencing Project

Patient Resources / Community

Patient resources on Influenza Genome Sequencing Project

Discussion groups on Influenza Genome Sequencing Project

Patient Handouts on Influenza Genome Sequencing Project

Directions to Hospitals Treating Influenza Genome Sequencing Project

Risk calculators and risk factors for Influenza Genome Sequencing Project

Healthcare Provider Resources

Symptoms of Influenza Genome Sequencing Project

Causes & Risk Factors for Influenza Genome Sequencing Project

Diagnostic studies for Influenza Genome Sequencing Project

Treatment of Influenza Genome Sequencing Project

Continuing Medical Education (CME)

CME Programs on Influenza Genome Sequencing Project

International

Influenza Genome Sequencing Project en Espanol

Influenza Genome Sequencing Project en Francais

Businness

Influenza Genome Sequencing Project in the Marketplace

Patents on Influenza Genome Sequencing Project

Experimental / Informatics

List of terms related to Influenza Genome Sequencing Project

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

The Influenza Genome Sequencing Project (IGSP) is an effort to dramatically improve the availability of genomic sequences and related information about the influenza (flu) viruses. The IGSP was started by Lone Simonsen (Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases), David Lipman and Steven Salzberg in early 2004, when they wrote a proposal to begin sequencing large numbers of influenza viruses at The Institute for Genomic Research (TIGR). The proposal was approved by the National Institutes of Health (NIH) and new technology development began that year, led by Elodie Ghedin at TIGR. Prior to this project, only a handful of flu genomes were publicly available. The project completed its first genomes in March 2005 and has rapidly accelerated since, with over 1800 genomes now in the public domain.

The project is funded by the National Institute of Allergy and Infectious Diseases (NIAID) which is a component of the NIH, which is an agency of the United States Department of Health and Human Services.

The sequencing effort, thus far conducted entirely at the NIAID Microbial Sequencing Center at TIGR, is revealing complete genetic blueprints of thousands of known human and avian influenza viruses. TIGR and NIAID are rapidly making all sequence information publicly available through GenBank, an international, searchable online database funded by NIH.

By putting critical genome knowledge in the public domain, project leaders hope to provide researchers with the information needed to develop new vaccines, therapies and diagnostics, and improve understanding of the overall molecular evolution of influenza and other genetic factors that determine their virulence. Such knowledge could not only help mitigate the impact of annual influenza epidemics, but could also improve scientific knowledge of the emergence of pandemic flu viruses.

The TIGR/NIAID IGSP has expanded to include a growing list of collaborators, who have contributed both expertise and valuable collections of influenza isolates. Key early contributors included Peter Palese of Mt. Sinai School of Medicine in New York, Jill Taylor of the Wadsworth Center at the New York State Department of Health, Lance Jennings of Canterbury Health Laboratories (New Zealand), Jeff Taubenberger of the Armed Forces Institute of Pathology (who later moved to NIH), Richard Slemons of Ohio State University and Rob Webster of St. Jude's Children's Hospital in Memphis, Tennessee. In 2006 the project was joined by Ilaria Capua of the Istituto Zooprofilattico Sperimentale delle Venezie (in Italy), who contributed a valuable collection of avian flu isolates (including multiple H5N1 strains). Nancy Cox from the Centers for Disease Control and Prevention (CDC) and Robert Couch from Baylor College of Medicine also joined the project in 2006, contributing over 150 influenza B isolates. The project will begin prospective studies of the 2007 influenza season with collaborators Florence Bourgeois and Kenneth Mandl of Children's Hospital Boston and the Harvard School of Public Health and Laurel Edelman of Surveillance Data Inc.

As of January 2007, 1813 isolates had been completely sequenced from influenza viruses that are endemic in human ("human flu") avian ("bird flu") and swine ("swine flu") populations, including many strains of H3N2 (human), H1N1 (human), and H5N1 (avian).

[1]

Further reading

Sources


WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools